I-Paclitaxel sisityalo sendalo esibizwa ngokuba yi-alkaloid ekuqaleni ekhutshwe kwiqabunga leqanda le-Taxus chinensis.
Indlela yokulwa nomhlaza yepaclitaxelIfumaneka ikakhulu ngokuphazamisana nenkqubo yeseli mitosis.Kwi-mitosis, iiseli zingena kwiinkqubo ezintsonkothileyo ezinjengokuphindaphindana kwechromosome, ukwahlukana, kunye nokunyakaza.I-Taxol inokudibanisa ne-tubulin ukuthintela i-tubulin ekubeni ipholima ibe yimiqulu yefiber, ngaloo ndlela iphazamisana nenkqubela phambili yesiqhelo ye-mitosis. .Oku kunokukhokelela ekubanjweni komjikelo weseli kwisigaba se-M, esikhokelela kwi-cell apoptosis okanye ukufa.
Ukongeza kwimpembelelo yayo ephazamisayo ngokuthe ngqo, i-paclitaxel inokusebenzisa iziphumo ze-anticancer ngokusebenzisa ezinye iindlela. amajoni omzimba, aphucula ukujongwa komzimba kunye nokukwazi ukucoca ngokuchasene namathumba.
Kwisicelo seklinikhi, i-paclitaxel isetyenziswe ngokubanzi kunyango lweentlobo zamathumba, kubandakanywa nomhlaza we-ovarian, umhlaza webele, umhlaza wemiphunga, umhlaza wesisu, njl njl.
Isishwankathelo, i-paclitaxel lichiza elinamandla lokulwa ne-tumor elineziphumo ezininzi ze-anticancer, kwaye liye laba yinxalenye ebalulekileyo yonyango lwe-tumor yeklinikhi. Kwixesha elizayo, sikholelwa ukuba ngophando olunzulu malunga nendlela yokusebenza kunye nokuphuculwa okuqhubekayo kweziyobisi, i-paclitaxel. iya kuba namandla amakhulu okuzisa iziphumo ezingcono kunyango lwezonyango lomhlaza.
Yunnan Hande Biotechnology Co., Ltd. sele egxile kwimveliso yepaclitaxelngaphezu kweminyaka engama-20.Lishishini elizimeleyo lemveliso yepaclitaxel imathiriyeli ekrwada, isityalo esikhupha iyeza le-anticancer, elivunywe yi-arhente yolawulo yelizwe njenge-FDA e-United States, i-EDQM eYurophu, i-TGA e-Australia, i-CFDA e-China, i-Indiya, ne-Japan.I-Yunnan Hande Taxol iyafumaneka kwisitokhwe kwaye ithengiswa ngokuthe ngqo ngabavelisi.Nceda uzive ukhululekile ukuqhagamshelana nathi ku-18187887160.
Ixesha lokuposa: May-25-2023